Operator of an integrated digital care platform intended to provide modern diagnostics-driven care.
Operator of an integrated digital care platform intended to provide modern diagnostics-driven care.
Diagnostic Equipment📍 Austin, TXFounded 2015
Current Valuation
$3.5B
as of 2021-Q1
UNICORN
QL Price
$958.36M
-72% vs last round
QuantLogix's current estimate for Everly Health, published 2026-09-27 — below the last disclosed round of $3.5B (2021-Q1).
Confidence
medium
Basis
secondary led
What backs this price
Last disclosed round
$3.5B
2021-Q1
weight 0.02
Secondary market print
$862.5M
2026-06-27
weight 0.58
How this price has held up
No round has priced for Everly Health since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-27 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Everly Health, 2026-09-27 (fda1f7ebc9a3ebb6).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is Everly Health going public?
No. Everly Health is private and has not filed to go public. There is no S-1 on file.
What is Everly Health's valuation in 2026?
Everly Health is valued at $3.5B as of 2021-Q1, set by its Series F ($154M, Mar 2021). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Everly Health filed an S-1?
No public S-1 is on file for Everly Health.
How much has Everly Health raised?
Everly Health has raised $619M in total, most recently a Series F of $154M in Mar 2021.
Is Everly Health publicly traded — can you buy Everly Health stock?
No. Everly Health is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Everly Health on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Founded
2015
HQ
Austin, TX
Employees
339
Total Raised
$619M
Last Round
Series F — $154M (Mar 2021)
IPO Status
private
Fundraising Status
Series F · $154M · 5y 6mo ago
privateTotal raised $619M
Secondary Market
Implied price / share
$16.14
Last round price / share
$64.45
vs last round
-75.0%
Open interest
1
Last round price vs secondary price
Secondary price return by period
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Series F
$154M
Mar 2021
—
$3.5B
Talent Signal
Hiring trend
▼ Hiring downtrend
-23% vs 2026-08
Open roles
17
via lever
Product-build share
53%
engineering, research, product, design
Trajectory
tightening
product-led hiring — 53% of open roles build product; the rest are go-to-market and G&A.
Open roles trending down; no tracked executive churn.
Counted from Everly Health's live job board as of 2026-09-15; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
MedicalHealth CareHealth Diagnostics
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2021-Q1. Refreshed quarterly.